• Home
• Responsibility
• CR Report 2004
• Community investment

Community investment

This section explains how we invest in communities. For information on our support for developing countries through preferential pricing and voluntary licensing see: Access to medicines.

GSK provides money, medicines, time and equipment to help improve health and education in under-served communities. We support public health initiatives and local community projects around the world and donate medicines to support disaster relief efforts and impoverished communities.

In 2004 our total community investment was valued at £328 million ($600 million), equivalent to 5.4% of pre-tax profits. Donations are made by our corporate contribution committees at group level and by individual GSK sites to support local communities.

This section provides information on the programmes we supported in 2004. It covers:

• A breakdown of our charitable donations in 2004.
• Donations of medicines for humanitarian purposes.
• Major health initiatives in developing countries to tackle. lymphatic filariasis (LF), HIV/AIDS, malaria, and diarrhoea-related disease.
• Community partnerships - local support provided at corporate level and by GSK sites.
• Our support for science education in the US and UK.
• How GSK employees are involved in our community investment.

We received a range of awards for our community investment activities during 2004, including:

• GSK was a finalist at the Committee to Encourage Corporate Philanthropy awards.
• PHASE was one of 10 winners at the World Business Awards organised by the UN Development Program, International Chamber of Commerce and International Business Leaders Forum for projects supporting the Millennium Development Goals.
• Disease Prevention and Education award for our PHASE project in the Pharmaceutical Achievement Awards.
• Runner up for Business in the Community’s European Impact Award for our work with Barretstown.
• Science Across the World, one of our business-education partnerships, received The Conference Board of Canada and International Partnership Network’s Global Best and European Language awards.

Back to top